Dexilant
developed for gastro-oesophageal reflux disease to support acid control.
Strengths: 30 · 60mg
Where to Check Availability
Medicine details
- Therapeutic class
Proton Pump Inhibitor
- Pharmacological class
Proton Pump Inhibitor
- Contraindications
hypersensitivity to dexlansoprazole
- Minor side effects
diarrhoea; abdominal pain; nausea
- Moderate side effects
flatulence; vomiting
- Dosage forms
Modified-release capsule, hard
- Administration route
Oral use
- Patient summary
developed for gastro-oesophageal reflux disease to support acid control.
- Prescription status
POM
- Manufacturer
Takeda
- Onset Time
1–2 hours
- Duration
24 hours
- Storage instructions
Store at room temperature below 25°C.
- Drug interactions
clopidogrel; methotrexate
- Age restrictions
Adults and adolescents 12 years and older.
- Pregnancy and breastfeeding
Consult your physician for advice if pregnant or breastfeeding.
Precautions and warnings
long-term use requires monitoring for vitamin B12 deficiency; risk of Clostridioides difficile infection
Serious side effects
anaphylaxis — requires immediate medical attention; interstitial nephritis — requires immediate medical attention
Mechanism of action
Dexlansoprazole is a proton pump inhibitor that suppresses gastric acid secretion by inhibiting the H+/K+-ATPase in the gastric parietal cells. This is effective for managing acid-related digestive symptoms.
Dexilant
developed for gastro-oesophageal reflux disease to support acid control.
Editorial Notes
- Active ingredient(s): Dexlansoprazole
- Listed indication(s): Gastro-oesophageal Reflux Disease, Erosive Oesophagitis
Usually available as
- 90 tablets - 30 mg1105-30-mg-13172
- 60 tablets - 60 mg1105-60-mg-13177